Journal of Fertility and Reproductive Health

ABSTRACT

Cervical cancer remains a significant global health challenge, with a particularly high prevalence in low and middle income countries, such as India. This report investigates disparities in cervical cancer incidence, risk factors, screening methodologies, and treatment outcomes between India and developed nations, aiming to identify key differences and suggest strategies for enhancing cervical cancer control in resource-limited settings. A multi-faceted methodology was employed, including an extensive literature review, data extraction from major health databases, surveys, and an analysis of reports from governmental and non-governmental organizations. The study applied descriptive and comparative statistical methods, trend analysis, and thematic analysis to comprehensively evaluate the data. Results indicate that India experiences markedly higher cervical cancer incidence and mortality compared to developed countries. Contributing factors include suboptimal HPV vaccination coverage, insufficient Pap smear screening, and regional variability in treatment options. In contrast, developed nations benefit from widespread HPV vaccination and robust screening programs, leading to lower cervical cancer rates and improved patient outcomes. The report underscores the need for strengthening prevention strategies in India by increasing HPV vaccination rates and expanding access to screening and treatment. Addressing these deficiencies is essential for reducing the burden of cervical cancer and enhancing patient.

Article History

Received 10 January 2024; Revised 08 February 2024; Accepted 15 February 2024

KEYWORDS

1. Uterine cervical neoplasms
2. Global health
3. Papillomavirus infections
4. Papanicolaou test